<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03586635</url>
  </required_header>
  <id_info>
    <org_study_id>18-PP-09</org_study_id>
    <nct_id>NCT03586635</nct_id>
  </id_info>
  <brief_title>Automated EDSS Score Calculation by Smartphone Application</brief_title>
  <acronym>Easy EDSS</acronym>
  <official_title>Automated EDSS Score Calculation Using a Smartphone Application in Multiple Sclerosis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EDSS score is the reference tool for rating disability in patients with multiple
      sclerosis. It is used in both daily monitoring and clinical research studies.

      Its main shortcoming lies in its imprecise and variable nature, with significant
      inter-examiner variability. This variability is the consequence of the complexity of the
      score rating and also of its subjective nature.

      The application developed aims to reduce the risk of rating error, and to homogenize the
      results obtained regardless of the examiner and his experience in using the score.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>EDSS score apllication VS paper version</measure>
    <time_frame>6 months</time_frame>
    <description>comparison of the overall EDSS score obtained with the application and its paper version at the end of the neurological examination</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">105</enrollment>
  <condition>MS CHRONIC PROGRESSIVE</condition>
  <arm_group>
    <arm_group_label>Patients with Multiple Sclerosis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>neurological exam</intervention_name>
    <description>Patients participating in the study are recruited from the investigator's tertiary multiple sclerosis management centre. They are systematically examined neurologically as part of their routine follow-up.
the patient will be exceptionally examined by two distinct persons, a senior doctor and a junior doctor (internal or external) independently.
At the end of the neurological examination, each examiner will evaluate the EDSS score in a classical way (using paper definitions) then using the smartphone application</description>
    <arm_group_label>Patients with Multiple Sclerosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - patients coming to the MS Competence and Recovery Centre
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with multiple sclerosis seen at the Central Nervous System Day Hospital as
             part of their follow-up and requiring neurological examination.

          -  Age â‰¥ 18 years

          -  No opposition to the use of their data

        Exclusion Criteria:

        - Neurological or general pathology, other than multiple sclerosis, that may interfere with
        EDSS score scoring
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie BONNARD</last_name>
      <phone>33492034588</phone>
      <email>bonnard.m@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 2, 2018</study_first_submitted>
  <study_first_submitted_qc>July 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2018</study_first_posted>
  <last_update_submitted>May 17, 2019</last_update_submitted>
  <last_update_submitted_qc>May 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

